LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. Financials - Benzinga

LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc.

LIPOOTCEM

Trade with Public

Trade with Public

$2.36

-0.35-12.75%

al cierre: Jun 17, 5:00 PM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar

LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. Financials

LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. (LIPO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Crude Oil Falls 1%; US Services PMI Declines In June

Avi Kapoor

Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook

Avi Kapoor

Dow Edges Higher; US Weekly Jobless Claims Increase

Avi Kapoor

Nasdaq Gains 1%; McDonald's Posts Downbeat Results

Avi Kapoor

Nasdaq Down Over 1%; Autoliv Raises FY23 Sales Outlook

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Friday. The Dow traded down 0.61% to 33,209.97 while the NASDAQ fell 1.24% to 13,022.16. The S&P 500 also fell, dropping, 0.96% to 4,236.78.

Lisa Levin

Gold Rises Over 1%; Schlumberger Shares Fall After Q3 Results

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.31% to 33,309.28 while the NASDAQ fell 1.09% to 13,042.83. The S&P 500 also fell, dropping, 0.73% to 4,246.72.

Lisa Levin

© 2026 Benzinga | All Rights Reserved